Andrew R. Hoffman
Academic Appointments
- Professor, Medicine - Endocrinology, Gerontology, & Metabolism
- Member, Child Health Research Institute
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Endocrinology Clinic 300 Pasteur Dr A175 MC 5303 Stanford, CA 94305 Tel Work (650) 723-6961 Fax (650) 725-8418
- Academic Offices
Personal Information Email Tel (650) 858-3930Alternate Contact Marina Braslavskaya Assistant Email Tel Work 650-725-9865Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Neuroendocrinology
- Endocrinology and Metabolism
Administrative Appointments
- Vice Chair for Academic Affairs, Department of Medicine, Stanford (2004 - present)
Professional Education
| Fellowship: | National Institutes of Health MD (1980) |
| Internship: | Massachusetts General Hosp., Harvard Med School MA (1977) |
| Board Certification: | Endocrinology and Metabolism, American Board of Internal Medicine (1981) |
| Residency: | Massachusetts General Hospital MA (1978) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1979) |
| Medical Education: | Stanford University School of Medicine CA (1976) |
Graduate & Fellowship Program Affiliations
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
The laboratory is interested in examining the role of insulin-like growth factors (IGF) in normal physiology and in oncogenesis. We are studying the molecular biology of IGF with an emphasis on long range chromatin interactions.
Publications
- Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med. 2007; (2): 104-15
- CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. Science. 2006; (5771): 269-72
- A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma. J Clin Invest. 2003; (2): 265-73
- Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain. Nat Genet. 1997; (1): 12-3
- Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature. 1994; (6499): 714-7
- Successful long-term treatment of Cushing disease with mifepristone (RU486). Endocr Pract. 2012 Sep-Oct; (5): e114-20
Help
Trial Administration